Read + Share
. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy
for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From
the Oesophagogastric Anastomosis Audit (OGAA). Ann Surg 2023;277:e1026-e1034.
PMID: 35099168
|
 |
|
